Amgen Inc. (AMGN) fundamentals from SEC filings — revenue $36.8B, net margin 21.0%, diluted EPS $14.23 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $26.0B | $26.3B | $28.2B | $33.4B | $36.8B |
| Net income | $5.9B | $6.6B | $6.7B | $4.1B | $7.7B |
| Net margin | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% |
| Diluted EPS | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 |
| Free cash flow | $8.4B | $8.8B | $7.4B | $10.4B | $8.1B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home